PECAM1 and breast cancer: To investigate the impact of DOX and BC treatment at the cellular level, 6 weeks after the beginning of the treatment, animals were euthanized, and tumors were excised and stained for CD31 (endothelial cell marker) and LM609 (αvβ3 integrins, biomarkers for angiogenesis).